| 13 May, 02:55 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Corporate Action-Board approves Dividend | bse |
| 13 May, 02:54 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Outcome Of Meeting | bse |
| 13 May, 02:49 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2026, recommended Final Dividend of Rs. 57 per equity share. | nse |
| 13 May, 02:47 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 22 Apr, 12:26 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ended 31St March 2026 And Dividend If Any | bse |
| 21 Apr, 11:46 am | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange Disclosure under Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 | nse |
| 21 Apr, 10:35 am | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Appointment of as Other of the company w.e.f. April 20, 2026. | nse |
| 21 Apr, 10:31 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 31 Mar, 05:01 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 31 Mar, 04:52 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 24 Mar, 12:13 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 24 Mar, 12:11 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 16 Mar, 06:00 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 16 Mar, 05:58 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 07 Mar, 05:34 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates | nse |
| 07 Mar, 05:33 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Postal Ballot Notice | bse |
| 07 Mar, 10:42 am | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 07 Mar, 10:37 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulations 30 | bse |
| 02 Mar, 12:20 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 02 Mar, 12:18 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 02, 2026. | nse |
| 02 Mar, 12:17 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 28 Feb, 04:07 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 28 Feb, 04:05 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulations 30 | bse |
| 23 Feb, 10:48 am | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 23 Feb, 10:40 am | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 16 Feb, 05:04 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 16 Feb, 04:58 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 11 Feb, 04:23 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 11 Feb, 04:21 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 09 Feb, 07:27 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 09 Feb, 07:24 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 09 Feb, 03:47 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 09 Feb, 03:44 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release". | nse |
| 09 Feb, 03:43 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Feb, 03:31 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Financial Results For Quarter & Nine Months December 2025 | bse |
| 09 Feb, 03:24 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Outcome for Outcome Of Meeting | bse |
| 09 Feb, 03:22 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 06 Jan, 03:54 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Un-Audited Financial Results For The Third Quarter & Nine Months Ended 31St December 2025. | bse |
| 01 Jan, 02:31 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 01 Jan, 02:28 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 31 Dec, 07:39 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 31 Dec, 07:38 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 31 Dec, 07:36 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Volume Movement Letter | bse |
| 31 Dec, 01:21 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd | bse |
| 31 Dec, 09:11 am | — | … | Significant increase in volume has been observed in GlaxoSmithKline Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. GlaxoSmithKline Pharmaceuticals Limited has submitted their response. | nse |
| 30 Dec, 06:21 pm | — | … | Significant increase in volume has been observed in GlaxoSmithKline Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | nse |
| 22 Dec, 12:36 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 22 Dec, 12:34 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |
| 18 Dec, 04:22 pm | — | … | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 18 Dec, 04:13 pm | — | … | GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30 | bse |